SAN ANTONIO – StemBioSys Inc. announced today that it has entered into an agreement with AXT PTY LTD to distribute and market StemBioSys products. AXT will distribute StemBioSys products in Australia and New Zealand.
The agreement will cover all of StemBioSys’ existing cell research products. As additional products are added to StemBioSys’ portfolio in the future, these will also be included in the distribution agreement, according to StemBioSys President & CEO Bob Hutchens.
“Australia and New Zealand are leading areas in cell research and we are delighted to have the opportunity to gain meaningful access to this market through our partnership with AXT,” Hutchens said. “AXT is a recognized life science tool company in Australia and New Zealand with deep technical expertise. AXT carries a full range of complementary products and we are very excited to announce them as our new distributor in these markets. We believe that this will be a great partnership for AXT, StemBioSys and for researchers in Australia and New Zealand” he said.
Richard Trett, Managing Director of AXT, said, “Australia is a leading light in medical research. Stem Cell research is a key area of development that holds great potential for many areas such as genetics and drug development. We are excited to be able to extend our range of tools that can assist with the ground-breaking work”.
About AXT PTY LTD.
AXT PTY LTD is a privately owned, diversified distributor of cutting edge scientific solutions for industry and academia. AXT serves market segments including life science, materials science, nanotechnology and mining. Distributorships range from multinationals through to small and innovative start ups
About StemBioSys Inc.
StemBioSys, Inc., a privately held, San Antonio-based biomedical company, manufactures and develops innovative cell and matrix technologies to support a broad range of research applications. The company markets its products globally to the research community under the CELLvo™ brand name. The company also partners with leading researchers around the world to develop new applications using its proprietary technologies.